| Synthesis, in-vitro screening, and docking analysis of novel pyrrolidine and piperidine-substituted ethoxy chalcone as anticancer agents SN Mokale, PN Dube, SA Bhavale, I Sayed, A Begum, MC Nevase, ... Medicinal chemistry research 24, 1842-1856, 2015 | 28 | 2015 |
| Design, synthesis and in vivo screening of some novel quinazoline analogs as anti-hyperlipidemic and hypoglycemic agents SN Mokale, AD Palkar, PN Dube, NS Sakle, PB Miniyar Bioorganic & Medicinal Chemistry Letters 26 (2), 272-276, 2016 | 24 | 2016 |
| Synthesis and biologic evaluation of substituted 5‐methyl‐2‐phenyl‐1H‐pyrazol‐3 (2H)‐one derivatives as selective COX‐2 inhibitors: molecular docking study PN Dube, SS Bule, SN Mokale, MR Kumbhare, PR Dighe, YV Ushir Chemical biology & drug design 84 (4), 409-419, 2014 | 24 | 2014 |
| Synthesis, biological screening and ADME prediction of benzylindole derivatives as novel anti-HIV-1, anti-fungal and anti-bacterial agents AM Kashid, PN Dube, PG Alkutkar, KG Bothara, SN Mokale, SC Dhawale Medicinal Chemistry Research 22, 4633-4640, 2013 | 18 | 2013 |
| Synthesis, in Vitro, and in Vivo Biological Evaluation and Molecular Docking Analysis of Novel 3‐(3‐oxo‐substitutedphenyl‐3‐)4‐(2‐(piperidinyl)ethoxy)phenyl … PN Dube, MN Waghmare, SN Mokale Chemical Biology & Drug Design 87 (4), 608-617, 2016 | 17 | 2016 |
| Synthesis, biological investigation and docking study of novel chromen derivatives as anti-cancer agents PN Dube, NS Sakle, SA Dhawale, SA More, SN Mokale Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 13 | 2019 |
| Synthesis of novel 5-methyl pyrazol-3-one derivatives and their in vitro cytotoxic evaluation PN Dube, SS Bule, YV Ushir, MR Kumbhare, PR Dighe Medicinal Chemistry Research 24 (3), 1070-1076, 2015 | 13 | 2015 |
| Synthesis and in-vivo hypolipidemic activity of some novel substituted phenyl isoxazol phenoxy acetic acid derivatives SN Mokale, MC Nevase, NS Sakle, PN Dube, VR Shelke, SA Bhavale, ... Bioorganic & Medicinal Chemistry Letters 24 (9), 2155-2158, 2014 | 13 | 2014 |
| CoMFA and docking study of 2, N6-disubstituted 1, 2-dihydro-1, 3, 5-triazine-4, 6-diamines as novel PfDHFR enzyme inhibitors for antimalarial activity PN Dube, S Mokale, P Datar Bulletin of Faculty of Pharmacy, Cairo University 52 (1), 125-134, 2014 | 10 | 2014 |
| Synthesis and molecular docking analysis of imidazol-5-one derivatives as anti-HIV NNRTIs PN Dube, SN Mokale, SI Shaikh, Y Patil, B Yadav, P Deshmukh, S Sabde Pharmaceutical Chemistry Journal 49, 125-131, 2015 | 8 | 2015 |
| Synthesis of some novel substituted phenylisoxazol phenoxy 2-methylpropanoic acids and there in vivo hypolipidemic activity SN Mokale, PN Dube, MC Nevase, NS Sakle, VR Shelke, SA Bhavale, ... Medicinal Chemistry Research 25 (3), 422-428, 2016 | 4 | 2016 |
| Design and Synthesis of Novel chalcone-phenylpyranone derivatives as estrogen receptor modulators PN Dube, YB Thombare, VA Chatpalliwar Multidisciplinary Digital Publishing Institute Proceedings 9 (1), 30, 2018 | 2 | 2018 |
| HIV-1 Integrase inhibitors: Update and perspectives PN Dube Journal of Chemical, Biological and Physical Sciences (JCBPS) 4 (2), 1152, 2014 | 2 | 2014 |
| 3, 5-Diphenylpyrazolylethanone Derivatives as Selective Estrogen Receptor Modulators: Design, Synthesis, Biological Evaluation and Docking Analysis PN Dube, VA Chatpalliwar Indo-Glob. J. Pharm. Sci 10 (1), 25-32, 2020 | 1 | 2020 |
| 2D QSAR of novel 2, N6-disubstituted 1, 2-dihydro-1, 3, 5-triazine-4, 6-diamines as potential antimalarial PN Dube, A Kashid, P Alkutkar, P Datar, P Gawade Journal of Chemical and Pharmaceutical Research 4 (1), 465-473, 2012 | 1 | 2012 |
| Development and validation of stability indicating RP-HPLC assay method for trospium chloride in tablet dosage form VD Kedar, PN Dube, SN Kapse, YB Thombare Research Journal of Pharmacy and Technology 17 (4), 1595-1598, 2024 | | 2024 |
| Design and Synthesis of Some Novel Pyrazole Derivatives as Selective Estrogen Receptor Modulators PN Dube Pune, 2020 | | 2020 |
| Development of Triazine-4, 6-diamines derivatives as potential Antimalarials: In-Silico Analysis PN Dube, PT Deshmukh, NP Jain MDPI AG, 2017 | | 2017 |
| Insight into the structural requirement for Anticancer Activity: Pharmacophore Generation and 3D QSAR Analysis PN DUBE, SN MOKALE, VA CHATPALLIWAR MDPI AG, 2015 | | 2015 |
